Index Pharmaceuticals welcomes investors, media and the public to virtually attend a Live Business Update Event on May 9, 2023 at 13.00.

 

Join us for an exciting company update event featuring InDex Pharmaceuticals, a Swedish phase 3 pharmaceutical development company with a mission to improve the lives of patients suffering from immunological diseases.

 

During the live broadcast event, you will have the chance to hear directly from InDex Pharmaceuticals’ leadership team who will share insights and updates on the company’s ongoing phase 3 CONCLUDE clinical program with the company’s lead asset, cobitolimod – a potential new medication for patients with ulcerative colitis.

 

Following the completion of the presentation, viewers will have the opportunity to ask questions through the webcast video chat.

 

Save the date and join us for this informative and inspiring event!